1/136
Flashcard deck covering pathophysiology, brain structures, and specific mental health conditions including depression, anxiety, schizophrenia, and the recovery model.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Main function of neurotransmitters
To transmit messages between neurons.
Synaptic cleft
The location where communication between two neurons occurs.
Three main components of a synapse
Presynaptic ending, synaptic cleft, and postsynaptic ending.
Presynaptic ending contents
Neurotransmitters (chemical messengers).
Postsynaptic ending contents
Receptor sites that receive signals.
Main functions of dopamine
Reward, pleasure, motivation, reinforcement, attention, learning, and movement.
Behavioural effects of reduced dopamine
Contribution to reduced motivation, reduced pleasure/reward, and decreased drive.
Neutrotransmitter effects in depression
Reduced dopamine, seratonin, noradrenaline
Neurotransmitter effects in schizophrenia
Excessive dopamine.
Neurotransmitter effects in Parkinson's disease
Dopamine depletion.
Neurotransmitter effects in anorexia nervosa
Overproduction of dopamine.
Factors serotonin contributes to
Mood, anxiety, sleep, appetite, emotional processing, and behaviour.
Neurotransmitter effects in OCD
Serotonin dysregulation.
SSRIs mechanism in depression and anxiety
They increase serotonin availability at the synapse.
GABA neurotransmitter type
The brain's major inhibitory neurotransmitter.
Inhibitory neurotransmitter function
Reduces neuronal excitability, making neurons less likely to fire.
GABA contributions
Regulation of anxiety, arousal, relaxation, sleep, and neuronal excitability.
Neurotransmitter effects in anxiety disorders
Reduced GABA, serotonin, norepinephrine. Increased glutamate
Effect of reduced GABA in anxiety
Less inhibitory signalling can cause increased neuronal excitability and arousal.
Benzodiazepines mechanism of action
They enhance the effects of GABA, increasing inhibitory neurotransmission and reducing neuronal excitability.
GABA abnormality in epilepsy
GABA dysregulation, potentially alongside excessive glutamate.
GABA change in Huntington's disease
Reduced GABA.
Glutamate neurotransmitter type
The brain's major excitatory neurotransmitter.
Excitatory neurotransmitter function
Increases neuronal activity and makes neurons more likely to fire.
Glutamate contributions
Neuronal excitation, learning, memory, and information processing.
Glutamate change in anxiety disorders
Increased excitability of glutamate.
Effect of increased glutamate in anxiety
Increased excitatory signalling can contribute to heightened neuronal arousal.
Neurotransmitter contributors to anxiety excitability
Reduced GABA and increased glutamate excitability.
GABA vs. glutamate analogy
GABA = brake; glutamate = accelerator.
Glutamate abnormality in epilepsy
Overproduction of glutamate and/or GABA dysregulation.
Norepinephrine alternate name
Noradrenaline.
Norepinephrine contributions
Alertness, attention, arousal, energy, concentration, and the stress response.
Norepinephrine change in depression
Reduced norepinephrine/noradrenaline.
Effect of reduced norepinephrine in depression
Contribution to low energy, poor concentration, and reduced alertness.
Norepinephrine change in anxiety disorders
Reduced norepinephrine.
Acetylcholine contributions
Learning, attention, memory, and muscle activation.
Acetylcholine abnormality in Alzheimer's disease
Decreased acetylcholine receptors.
Neurotransmitter reductions in depression (summary)
Reduced noradrenaline, dopamine, and serotonin.
Neurotransmitter abnormality in OCD (summary)
Serotonin dysregulation.
Neurotransmitter changes in anxiety disorders (summary)
Reduced GABA, serotonin and norepinephrine, with increased glutamate excitability.
Neurotransmitter abnormality in schizophrenia (summary)
Excessive dopamine.
Neurotransmitter abnormality in Alzheimer's (summary)
Decreased acetylcholine receptors.
Neurotransmitter abnormality in Parkinson's (summary)
Dopamine depletion.
Neurotransmitter abnormalities in epilepsy (summary)
GABA dysregulation and/or glutamate overproduction.
Neurotransmitter abnormality in Huntington's (summary)
Reduced GABA.
Dopamine direction: Depression vs Schizophrenia
In depression, dopamine is reduced while in schizophrenia, dopamine is excessive.
Serotonin link across conditions
Serotonin is reduced in depression and anxiety, and dysregulated in OCD.
Frontal lobe function
Motor skills, planning, expression, reasoning, and problem solving.
Conditions associated with the frontal lobe
Mania, major depressive disorder, anxiety, personality disorders, bulimia nervosa, ADHD, and autism spectrum disorder.
Parietal lobe function
Translates signals such as touch, pain, and pressure; contributes to orientation and recognition.
Condition associated with the parietal lobe
Schizophrenia.
Occipital lobe function
Processes visual information.
Condition associated with the occipital lobe
Schizophrenia.
Temporal lobe function
Processes sounds and contributes to memory and speech perception.
Conditions associated with the temporal lobe
Schizophrenia, anxiety, and major depressive disorder.
Thalamus contributions
Pain perception, motor control, auditory and visual processing, and emotional expression.
Conditions associated with the thalamus
Schizophrenia, PTSD, and major depressive disorder.
Hypothalamus function
Regulates bodily functions including sleep, hunger, and thirst.
Conditions associated with the hypothalamus
Schizophrenia and major depressive disorder.
Amygdala function
Processes fear and anxiety and is involved in the fight-flight-freeze response.
Conditions associated with the amygdala
Anxiety, borderline personality disorder, major depressive disorder, anorexia nervosa, and bulimia nervosa.
Hippocampus function
Contributes to learning, development, emotional behaviour, and recalling happy and traumatic events.
Condition associated with the hippocampus
Major depressive disorder.
Depression (Definition)
A mood state characterised by significantly lowered mood and loss of interest or pleasure in normally enjoyable activities.
Depression mood vs. normal sadness
Distinguished by severity, persistence, duration, and characteristic symptoms.
Reduced neurotransmitters in depression pathophysiology
Noradrenaline, dopamine, and serotonin.
Emotional symptoms of depression
Depressed mood, loss of interest/enjoyment, reduced self-esteem/confidence, guilt, worthlessness, hopelessness, and pessimism.
Physical or behavioural symptoms of depression
Psychomotor agitation or retardation, sleep disturbance, appetite/weight changes, decreased libido, fatigue, and reduced concentration.
DSM-5 symptom threshold for major depression
5 or more symptoms during the same 2-week period, representing a change from previous functioning.
Mandatory core symptoms for major depression
Depressed mood OR loss of interest/pleasure.
Comprehensive depression assessment components
History/trauma, safety/psychological functioning, biopsychosocial assessment, MSE, physiological/psychomotor activity, behaviour/social activity, medical conditions, and drug reactions.
Suicide risk determination factors
Plan, intent, means/access, previous suicidal behaviours, risk factors, and protective factors.
CPR (Suicide risk acronym)
Current plan, Past history, Resources (including internal and external protective factors).
Examples of suicide protective factors
Social/emotional support, peer/family relationships, community connection, employment, stable income, and stable housing.
Identified psychotherapy and non-drug treatments for depression
Psychotherapy, CBT, brief dynamic therapy, family therapy, ECT, light therapy, and transcranial magnetic stimulation.
Patient monitoring in depression
Monitoring mood, mental state, and risk, plus documentation of findings.
Health-focused nursing interventions for depression
Healthy eating/exercise, adaptive coping, meaningful activities, and support groups.
Therapeutic nursing interventions for depression
Monitor MSE/risk, administer medications, psychoeducation, and CBT or motivational interviewing techniques.
Anxiety (Definition)
A state involving apprehension and activation of the autonomic nervous system in response to a vague, non-specific threat.
Normal vs. problematic anxiety
Normal is a short-term fight-or-flight response; problematic occurs when arousal becomes constant or prolonged.
Anxiety neurotransmitter changes
Reduced GABA, serotonin, and norepinephrine with increased glutamate excitability.
Generalised Anxiety Disorder (GAD)
Excessive, difficult-to-control anxiety and worry about multiple events or activities with restlessness or muscle tension.
Panic disorder
Recurrent unexpected panic attacks without triggers plus concern about more attacks or maladaptive behavioural change.
Agoraphobia
Fear of situations where escape is difficult or help unavailable if panic symptoms occur, leading to avoidance.
Specific phobia
Marked, unreasonable fear or anxiety about a specific object or situation that is actively avoided.
Social anxiety disorder
Excessive fear or anxiety about social situations involving possible scrutiny by others, leading to avoidance.
Obsession (OCD)
Recurrent persistent thoughts, urges, or images experienced as intrusive and unwanted that cause marked anxiety or distress.
Compulsion (OCD)
A repetitive behaviour or mental act that the person feels driven to perform to reduce anxiety generated by obsessions.
OCD (Neurotransmitter abnormality)
Serotonin dysregulation.
Assessment tool for GAD
GAD-7.
Assessment tool for OCD severity and impact
Yale-Brown Obsessive Compulsive Scale (Y-BOCS).
Interventions for anxiety disorders
Psychoeducation, social support, trauma-informed care, CBT, distraction, cultural support, relaxation/mindfulness, and medication.
Benzodiazepine action mechanism
They potentiate GABA, inhibiting neurotransmission and decreasing anxiety.
Diazepam
An example of a benzodiazepine identified in the lecture.
Alprazolam
An example of a benzodiazepine identified in the lecture.
Lorazepam
An example of a benzodiazepine identified in the lecture.
Clonazepam
An example of a benzodiazepine identified in the lecture.
Monitoring for benzodiazepines
Nurses monitor for over-sedation, cognitive impairment, and dependence.
Benzodiazepines and alcohol
Patients should not combine these medications with CNS depressants like alcohol.
Benzodiazepines safety warnings
Avoid driving and operating machinery.